Transcatheter Arterial Chemoembolization Combined With Sorafenib for Unresectable Hepatocellular Carcinoma
Clinical trial NCT01833299 · COMPLETED
Trial details
- NCT number
- NCT01833299
- Sponsor
- Sun Yat-sen University
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-01-01
- Primary completion
- 2016-12-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.